ScholarIQanswers from OpenAlex

Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers

PaperCitations, authors & open-access status

Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers have?

ScholarIQcitation count

Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers has 559 citations in the OpenAlex counts ScholarIQ stores.

When was Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers published?

ScholarIQyear

Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers has 2021 year in the ScholarIQ index.

What is the open-access status of Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers?

ScholarIQoa status

Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers has hybrid oa status in the ScholarIQ index.

What is the DOI of Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers?

ScholarIQdoi

The DOI for Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers is on the source record.

What is the PMID of Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers?

ScholarIQpmid

The PMID for Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers is on the source record.

What is the OpenAlex record for Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers?

ScholarIQopenalex

The OpenAlex for Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial